Oura’s Confidential IPO Filing Marks a New Phase for Smart Rings
Oura, maker of the Oura Ring, has confidentially filed paperwork with the US Securities and Exchange Commission for an initial public offering of its common stock, working with major banks including Goldman Sachs, Morgan Stanley, and JPMorgan Chase. While the company has not yet revealed how many shares it will offer, the price range, or the exact listing date, insiders expect the Oura Ring IPO to land later this year, subject to market conditions and regulatory review. Founded in 2013, Oura has grown from niche wellness gadget to one of the most recognizable names in the smart ring market, selling millions of devices and building a subscription-based software business around sleep, readiness, and recovery insights. Its decision to enter public markets places it alongside a new wave of high‑profile tech listings and underscores the rising prominence of health‑focused consumer hardware.
An $11 Billion Oura Valuation Signals Investor Confidence in Smart Rings
Oura’s IPO plans come on the heels of a USD 900 million (approx. RM4,140 million) Series E funding round completed in October 2025, which pushed the company’s valuation to approximately USD 11 billion (approx. RM50,600 million). Earlier, Oura also raised USD 875 million (approx. RM4,025 million), reflecting strong investor appetite for the smart ring market and for health wearables IPO opportunities more broadly. The company reported more than USD 500 million (approx. RM2,300 million) in 2024 revenue and indicated it was on track to double that performance in 2025, targeting over USD 1 billion (approx. RM4,600 million) in annual sales, though full 2025 figures have not yet been disclosed. CEO Tom Hale previously stated that Oura had sold 5.5 million rings and expected revenue to grow to USD 1.5 billion (approx. RM6,900 million) this year, effectively tripling its 2024 results. Together, these metrics help justify Oura’s lofty valuation and signal growing trust in ring‑based health tracking.
From Wellness Gadget to Health Data Hub
Although the Oura Ring is officially classified as a consumer wellness product, its trajectory shows how consumer wearables are moving closer to the medical device ecosystem. Oura has forged strategic alliances that turn the ring into a hub for multi‑dimensional health data. A notable example is Dexcom’s USD 75 million (approx. RM345 million) investment, tied to a partnership that integrates continuous glucose monitoring data with Oura’s sleep, stress, and cardiovascular metrics. This allows users to explore how factors like poor sleep or specific meals influence glucose variability. Oura has also partnered with femtech company Mira, enabling users to access lab‑grade hormone testing data alongside everyday ring metrics. These integrations reposition Oura from a single‑purpose sleep tracker to a broader health insights platform, blurring the line between consumer gadgets and clinical‑grade tools and enhancing its appeal to both investors and health‑conscious consumers.
Membership Growth and Product Strength Underpin Oura’s IPO Story
Beyond hardware sales, Oura’s membership base is a central part of its growth narrative. The company recently announced it is on course to surpass five million paid members this quarter, representing a four‑fold increase over the past two years. This subscription engine complements hardware revenue and provides recurring income that public markets typically reward. Reviews of the latest Oura Ring, including the Ring 4, highlight the device as a “technological marvel” in its category, praised for packing advanced sensors and analytics into a discreet form factor. By focusing on sleep quality, readiness scores, and detailed health trends, Oura has differentiated itself from traditional fitness trackers and smartwatches. As it prepares for a health wearables IPO, this combination of a loyal subscriber base, rapid revenue growth, and strong product reviews offers a compelling story to investors seeking exposure to consumer health technology.
What Oura’s Public Debut Means for the Future of Health Wearables
Oura’s move toward the public markets is a watershed moment for the smart ring market and for consumer health wearables at large. An Oura Ring IPO at an USD 11 billion (approx. RM50,600 million) valuation sends a strong signal that ring‑based health monitoring is no longer a fringe niche but a credible alternative to wrist‑worn devices. If the listing is successful, it could catalyse more competition, spurring both startups and established tech giants to invest in compact, sensor‑rich rings and new health‑centric form factors. Investors will watch how Oura balances rapid innovation with regulatory expectations as its products edge closer to clinical workflows. For consumers, Oura’s public debut could translate into faster feature rollouts, deeper integrations with medical partners, and broader availability. More broadly, it marks a milestone in the mainstreaming of continuous, everyday health tracking as part of standard consumer technology.